PROM1 and cancer: The results showed that the CD133+ ACC-M had more capability of migration and invasion than CD133− ACC-M cells (Figure 3C, 3D), indicating that CD133+ ACC-M, cancer stem-like cells, promoted ACC migration and invasion.